⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

November 4, 2026American Journal of Respiratory and Critical Care Medicine

End of the Beginning: The Second Generation of Anti-fibrotic Therapy Grows

Toby M. Maher Justin Oldham Anna J. Podolanczuk

View at Publisher

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

Toby M Maher, Justin Oldham, Anna J Podolanczuk; End of the Beginning: The Second Generation of Anti-fibrotic Therapy Grows, American Journal of Respirator

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Maher et al. (2026) studied this question.

synapsesocial.com/papers/6aeec02e2765dd7d89fe559b https://doi.org/10.1093/ajrccm/aamag594

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Getting the Timing Right: Controlling BCL-2 Inhibition as an Antifibrotic TherapyOriginal Research · 2024 · 1 citations
2Investigational insights into the potential of angiotensin type II receptor agonists as therapeutics for idiopathic pulmonary fibrosisreview · 2026 · 1 citations
3Perspective: Nerandomilast and the Evolving Therapeutic Paradigm in Pulmonary Fibrosis—From Mechanism to Clinical EfficacyHuman Clinical Trial · 2026
4Gradually, then suddenly: Deconvoluting the natural history of idiopathic pulmonary fibrosisOriginal Research · 2026
5Cardiac fibrosis: emerging agents in preclinical and clinical developmentreview · 2020 · 19 citations
6Emerging Therapies in Pulmonary Fibrosis: A Common Pathway for the Action of Diverse Pharmacologic AgentsClinical Trial · 2026
7Most Promising Emerging Therapies for Pulmonary Fibrosis: Targeting Novel PathwaysLate-Phase Clinical Trial · 2026 · 15 citations
8Pulmonary fibrosis: evolving therapeutic pipelineHuman Clinical Trial · 2026
9Complementing the picture: adding antithrombin III monitoring in extracorporeal carbon dioxide removalAmerican Journal of Respiratory and Critical Care Medicine · 2026
10GDF-15 as an early marker for prognosis in patients with out-of-hospital cardiac arrest – Experience from the HAnnover COoling REgistryAmerican Journal of Respiratory and Critical Care Medicine · 2026

More from American Journal of Respiratory and Critical Care Medicine

More from University of Michigan

More from Imperial College London

More from University of Southern California

More from Michigan Medicine

More from Weill Cornell Medicine